DrugPatentWatch Database Preview
Details for Patent: 6,258,795
Which drugs does patent 6,258,795 protect, and when does it expire?
Patent 6,258,795 protects VISTOGARD and XURIDEN and is included in two NDAs.
This patent has one hundred and seventy-five patent family members in twenty-one countries.
Summary for Patent: 6,258,795
| Title: | Acylated uridine and cytidine and uses thereof |
| Abstract: | The invention relates to compositions comprising acyl derivatives of cytidine and uridine. The invention also relates to methods of treating hepatopathies, diabetes, heart disease, cerebrovascular disorders, Parkinson's disease, infant respiratory distress syndrome and for enhancement of phospholipid biosynthesis comprising administering the acyl derivatives of the invention to an animal. |
| Inventor(s): | von Borstel; Reid Warren (Darnestown, MD), Bamat; Michael Kevin (Darnestown, MD) |
| Assignee: | Pro-Neuron, Inc. (Gaithersburg, MD) |
| Application Number: | 08/466,145 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Formulation; Dosage form; |
Drugs Protected by US Patent 6,258,795
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wellstat Therap | VISTOGARD | uridine triacetate | GRANULE;ORAL | 208159-001 | Dec 11, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| Wellstat Therap | XURIDEN | uridine triacetate | GRANULE;ORAL | 208169-001 | Sep 4, 2015 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,258,795
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 142221 | Start Trial | |||
| Austria | 179615 | Start Trial | |||
| Austria | 205850 | Start Trial | |||
| Austria | 243039 | Start Trial | |||
| Austria | 282627 | Start Trial | |||
| Austria | 320813 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
